A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU [fluorouracil] in Patients With Highly Advanced Hepatocellular Carcinoma.

Trial Profile

A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU [fluorouracil] in Patients With Highly Advanced Hepatocellular Carcinoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 May 2016

At a glance

  • Drugs Interferon alpha (Primary) ; Cisplatin; Fluorouracil
  • Indications Liver cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 01 Feb 2012 Results published in Hepatology Research.
    • 21 Jul 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
    • 21 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top